This note was first published as evidence submitted to the joint inquiry of the UK All-Party Parliamentary Groups (APPGs) on WASH and Antibiotics into the links between antibiotic resistance and lack of access to WASH.

In the fall of 1968, when I was 22 and starting the second year of a two-year master’s program at the Johns Hopkins School of International Studies in Washington, DC, the man who would become my first husband told me about a college friend in New York needing $200 to help pay for an illegal but reas...

As one of the only truly global institutions, the World Bank is uniquely positioned to be the world’s premier source funding for global public goods. But despite its global coverage, the World Bank has never truly been oriented towards global challenges. Its mission has been defined primarily by ind...

This note takes a quick look at the lessons learned and the existing landscape of MCM manufacturing in the context of the current pandemic response and suggests eight areas for action along with near-term recommendations to the global community to both prepare and respond to future pandemic risks. 

While oral antivirals are not a substitute for vaccination, they are key to preventing severe illness, saving lives, and preserving health systems. Vaccination rates continue to be low in low-income countries; only 14 percent of the population in low-income countries has received one dose of the vac...

The COVID-19 pandemic has transformed the global vaccine manufacturing landscape, with capacity more than doubling in the past 18 months. Before the pandemic, manufacturers produced an estimated total of five billion vaccine doses each year. In 2021, manufacturers produced 12 billion doses of C...

Corrective taxes on harmful products—health taxes—are a cost-effective way to save lives and generate additional tax revenue. In new research, we show that health tax measures during COVID-19 have diminished in number and strength because the international community has mobilized additional, largely...